Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Metastatic Colorectal Cancer
94%
Circulating Tumor DNA
79%
Chemotherapy
62%
Overall Survival
61%
Biological Marker
58%
Progression Free Survival
45%
Colorectal Carcinoma
37%
Ovary Cancer
31%
Malignant Neoplasm
29%
Metastasis
26%
Bevacizumab
25%
Epidermal Growth Factor Receptor
23%
Phase II Trials
23%
Irinotecan
22%
Disease
20%
Ovary Carcinoma
19%
Rectum Cancer
17%
Lung Cancer
14%
Capecitabine
13%
Epidermal Growth Factor
12%
Non Small Cell Lung Cancer
12%
Vasculotropin
11%
Alpha Tocotrienol
11%
Breast Cancer
11%
Biliary Tract Cancer
11%
Chemoradiation Therapy
11%
Gemcitabine
11%
microRNA
11%
Colon Carcinoma
11%
Neuropeptide Y
10%
Interleukin 6
10%
Solid Malignant Neoplasm
10%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
9%
Receptor
9%
Vasculotropin A
8%
Recurrent Disease
8%
Oxaliplatin
8%
Tumor Marker
8%
Cetuximab
8%
Combination Therapy
8%
Prospective Study
8%
Monotherapy
7%
Adverse Event
7%
Ovary Tumor
7%
Carboplatin
7%
SARS Coronavirus
5%
Regorafenib
5%
DNA A
5%
Postcholecystectomy Syndrome
5%
Biochemistry, Genetics and Molecular Biology
Circulating Tumor DNA
76%
Blood Plasma
69%
Overall Survival
42%
HOXA9
42%
Methylation
40%
Single-Nucleotide Polymorphism
40%
KRAS
32%
Progression Free Survival
30%
MicroRNA
29%
Homeobox
29%
Droplet Digital Polymerase Chain Reaction
21%
Real-Time Polymerase Chain Reaction
21%
Vascular Endothelial Growth Factor A
19%
DNA Methylation
19%
Genotyping
18%
Vascular Endothelial Growth Factor
17%
Bevacizumab
17%
Wild Type
14%
Capecitabine
13%
Dynamics
12%
Colon
12%
Growth Factor-Like Domain
11%
Natural Killer Cell
11%
Epidermal Growth Factor
11%
Gemcitabine
11%
Poly ADP Ribose Polymerase
11%
Allele
11%
Multivariate Analysis
10%
Cell Activity
10%
Embase
9%
Clinical Trial
8%
Epidermal Growth Factor Receptor
8%
Medline
8%
Phase II Trials
8%
Kinase Insert Domain Receptor
7%
Gene Polymorphism
7%
TaqMan
7%
Computer Assisted Tomography
7%
Web of Science
7%
Cochrane Library
7%
Liquid
6%
Quantitative Technique
6%
Mir-126
6%
Copurification
6%
Tumor Marker
5%
Exon
5%
Intracellular Signaling
5%
Patient Coding
5%
DnaA
5%
Comorbidity
5%
Medicine and Dentistry
Cell-Free DNA
45%
Colorectal Carcinoma
40%
Circulating Tumor DNA
39%
Biological Marker
28%
Neoplasm
28%
Specific Tumor
28%
Ovarian Cancer
23%
Methylation
19%
Malignant Neoplasm
19%
Rectum Cancer
19%
Metastatic Colorectal Cancer
19%
Lung Cancer
17%
Meta-Analysis
17%
Systematic Review
17%
Chemoradiotherapy
17%
Progression Free Survival
17%
Overall Survival
16%
Chemotherapy
14%
DNA Methylation
12%
Diagnosis
12%
Gemcitabine
11%
Capecitabine
11%
Biliary Tract Cancer
11%
Bevacizumab
11%
Breast Cancer
11%
Homeobox
11%
Metastatic Carcinoma
11%
Disease
11%
Krukenberg Tumor
10%
Droplet Digital Polymerase Chain Reaction
10%
Receptor
9%
Treatment Response
9%
Gene Expression
9%
Hazard Ratio
8%
Phase II Trials
8%
Real-Time Polymerase Chain Reaction
8%
Lung Metastasis
8%
Irinotecan
7%
Multivariate Analysis
7%
Ovarian Tumor
7%
microRNA 21
7%
Reproducibility
6%
High Risk Population
6%
Prospective Study
6%
Arm
5%
Antisense
5%
Erlotinib
5%
Alpha Tocotrienol
5%
Epidermal Growth Factor Receptor
5%
DNA A
5%